1. Journal Papers

This table browses all dspace content
Issue DateTitleJournal Title
2023Global prevalence, cascade of care, and prophylaxis coverage of hepatitis B in 2022: a modelling studyLANCET GASTROENTEROLOGY & HEPATOLOGY
2023Genomic analysis of plasma circulating tumor DNA in patients with heavily pretreated HER2 + metastatic breast cancer SCIENTIFIC REPORTS
2023Final Report on Real-World Effectiveness of Sequential Afatinib and Osimertinib in EGFR-Positive Advanced Non-Small Cell Lung Cancer: Updated Analysis of the RESET Study CANCER RESEARCH AND TREATMENT
2023Fibroblast growth factor-23 and cardiovascular disease among prevalent hemodialysis patients focusing on residual kidney function FRONTIERS IN ENDOCRINOLOGY
2023Feasibility of UTE-MRI-based radiomics model for prediction of histopathologic subtype of lung adenocarcinoma: in comparison with CT-based radiomics modelEUROPEAN RADIOLOGY
2023External Validation of the eCura System for Undifferentiated-Type Early Gastric Cancer with Noncurative Endoscopic Resection GUT AND LIVER
2023Evaluation and Management of Patients with Diabetes and Heart Failure: A Korean Diabetes Association and Korean Society of Heart Failure Consensus Statement DIABETES & METABOLISM JOURNAL
2023Evaluating the Safety and effectivenesS in adult KorEaN patients treated with Tolvaptan for management of autosomal domInAnt poLycystic kidney disease (ESSENTIAL): short-term outcomes during the titration period KIDNEY RESEARCH AND CLINICAL PRACTICE
2023Eflapegrastim versus Pegfilgrastim for Chemotherapy-Induced Neutropenia in Korean and Asian Patients with Early Breast Cancer: Results from the Two Phase III ADVANCE and RECOVER Studies CANCER RESEARCH AND TREATMENT
2023Efficacy and safety of pembrolizumab monotherapy in patients with advanced thyroid cancer in the phase 2 KEYNOTE-158 studyCANCER
2023Efficacy and safety of HIP1601 (dual delayed-release esomeprazole) 40 mg in erosive esophagitis compared to HGP1705 (delayed-release esomeprazole) 40 mg: a multicenter, randomized, double-blind, non-inferiority study BMC GASTROENTEROLOGY
2023Efficacy and Safety of Fexuprazan in Patients with Acute or Chronic Gastritis GUT AND LIVER
2023Efficacy and safety of enavogliflozin versus dapagliflozin added to metformin plus gemigliptin treatment in patients with type 2 diabetes: A double-blind, randomized, comparator-active study: ENHANCE-D study DIABETES & METABOLISM
2023Effects of underweight and overweight on mortality in patients with pulmonary tuberculosis FRONTIERS IN PUBLIC HEALTH
2023Effects of continuous positive airway pressure therapy on left ventricular performance in patients with severe obstructive sleep apnea SCIENTIFIC REPORTS
2023Effectiveness of low-intensity atorvastatin 5 mg and ezetimibe 10 mg combination therapy compared with moderate-intensity atorvastatin 10 mg monotherapy: A randomized, double-blinded, multi-center, phase III study MEDICINE
2023Early Circulating Tumor DNA Dynamics and Efficacy of Lorlatinib in Patients With Treatment-Naive, Advanced, ALK-Positive NSCLC JOURNAL OF THORACIC ONCOLOGY
2023Early Aortic Valve Replacement in Symptomatic Normal-Flow, Low-Gradient Severe Aortic Stenosis: A Propensity Score-Matched Retrospective Cohort Study KOREAN CIRCULATION JOURNAL
2023Dynamic changes in peripheral blood monocytes early after anti-PD-1 therapy predict clinical outcomes in hepatocellular carcinoma CANCER IMMUNOLOGY IMMUNOTHERAPY
2023Dual antiplatelet therapy duration after percutaneous coronary intervention in high bleeding risk: a meta-analysis of randomized trialsEUROPEAN HEART JOURNAL

Recent Submissions

Browse

Links